Featured Reviews on Nanomaterials and Nanotechnology for Biology and Medicines

A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".

Deadline for manuscript submissions: 20 July 2024 | Viewed by 1380

Special Issue Editor


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

Nanomaterials have been identified in various environmental settings and are present across all forms of life, from bacteria to archaea and eukaryota. The potential adverse effects of these nanomaterials, including changes in normal composition and accumulation in organisms, can impact protists, plants, fungi, and animals. Moreover, their expanding use in agriculture, healthcare, and medicine further increases exposure to living organisms.

This Special Issue seeks high-quality review papers encompassing all fields of nanomaterials for biology and medicine. We warmly encourage researchers from related fields to contribute review papers that highlight the latest advancements, including bio-nanomaterials, nanomedicines, drug and gene delivery, cancer therapy, wound healing, tissue engineering, diagnostics, bio-imaging, antimicrobial applications, immune system modulation, biocompatibility, biomimetic properties, and 3D bioprinting, among others. Full-length comprehensive reviews will be given preference for inclusion in this impactful Special Issue.

Prof. Dr. Eleonore Fröhlich
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bio-nanomaterials
  • nanomedicines
  • nanotoxicology and nanosafety
  • nano-bio interactions and mechanisms
  • nanotechnology in drug and gene delivery
  • nanotechnology in cancer therapy
  • nanotechnology in wound healing
  • nanotechnology in tissue engineering
  • nanotechnology in diagnostics and imaging
  • nanotechnology for antimicrobial applications
  • nano-immunotherapy and immune system modulation
  • biocompatibility
  • biomimetic nanomaterials for medical applications
  • 3D bioprinting

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

30 pages, 2716 KiB  
Review
Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance
by Sydney Kusumoputro, Christian Au, Katie H. Lam, Nathaniel Park, Austin Hyun, Emily Kusumoputro, Xiang Wang and Tian Xia
Nanomaterials 2024, 14(1), 67; https://doi.org/10.3390/nano14010067 - 26 Dec 2023
Viewed by 1183
Abstract
Liver-targeting nanoparticles have emerged as a promising platform for the induction of immune tolerance by taking advantage of the liver’s unique tolerogenic properties and nanoparticles’ physicochemical flexibility. Such an approach provides a versatile solution to the treatment of a diversity of immunologic diseases. [...] Read more.
Liver-targeting nanoparticles have emerged as a promising platform for the induction of immune tolerance by taking advantage of the liver’s unique tolerogenic properties and nanoparticles’ physicochemical flexibility. Such an approach provides a versatile solution to the treatment of a diversity of immunologic diseases. In this review, we begin by assessing the design parameters integral to cell-specific targeting and the tolerogenic induction of nanoplatforms engineered to target the four critical immunogenic hepatic cells, including liver sinusoidal epithelial cells (LSECs), Kupffer cells (KCs), hepatic stellate cells (HSCs), and hepatocytes. We also include an overview of multiple therapeutic strategies in which nanoparticles are being studied to treat many allergies and autoimmune disorders. Finally, we explore the challenges of using nanoparticles in this field while highlighting future avenues to expand the therapeutic utility of liver-targeting nanoparticles in autoimmune processes. Full article
Show Figures

Figure 1

Back to TopTop